glp-1 crohn's disease The role of RA in inflammatory bowel disease. The GLP-1 RA GLP-1 for Crohn's Disease: Current

Reducing inflammation can improve insulin sensitivity and overall metabolic health, potentially decreasing the need for GLP-1 drugs

The mechanism behind this effect has been investigated using direct reactive quenching and has been linked to the antioxidant activity of DPP4 inhibitors

Our work therefore establishes a foundation for future translational studies and highlights an overlooked domain of GLP-1RA safety that has direct relevance for dentistry, endocrinology, and patient care

If symptoms persist beyond the early titration period, temporary dose stabilization or dose reduction should be considered

Metformin, for example, has demonstrated both beneficial and adverse effects

These trials included individuals who were in varying degrees of renal failure